Gossamer Bio Stock Performance
| GOSS Stock | USD 2.73 0.00 0.00% |
On a scale of 0 to 100, Gossamer Bio holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of 1.4, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Gossamer Bio will likely underperform. Please check Gossamer Bio's potential upside, as well as the relationship between the accumulation distribution and relative strength index , to make a quick decision on whether Gossamer Bio's current trending patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Gossamer Bio are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Gossamer Bio unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (5.92) | Five Day Return 11.11 | Year To Date Return (6.25) | Ten Year Return (84.95) | All Time Return (84.95) |
1 | Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update | 11/05/2025 |
2 | How Gossamer Bio Inc. stock moves in volatile trading sessions - newser.com | 11/19/2025 |
3 | Gossamer Bio, Inc.s 28 percent Share Price Surge Not Quite Adding Up | 11/25/2025 |
4 | Gossamer Bio Stock Price Up 5.9 percent - Still a Buy - MarketBeat | 12/04/2025 |
5 | Gossamer Bio Stock Price Up 5.1 percent - Heres What Happened - MarketBeat | 12/15/2025 |
6 | Gossamer Bio High Risk Binary Approaches - Seeking Alpha | 12/19/2025 |
7 | Gossamer Bio, Inc. Receives 8.50 Consensus Target Price from Analysts | 12/22/2025 |
8 | Acquisition by Robert Smith of 162500 shares of Gossamer Bio subject to Rule 16b-3 | 12/31/2025 |
9 | Acquisition by Christian Waage of 506250 shares of Gossamer Bio at 2.88 subject to Rule 16b-3 | 01/02/2026 |
10 | Gossamer Bio Shares Down 6.8 percent - Whats Next - MarketBeat | 01/06/2026 |
11 | Gossamer Bio Trading Down 5.7 percent Heres What Happened | 01/23/2026 |
| Begin Period Cash Flow | 32.1 M | |
| Total Cashflows From Investing Activities | 29 M |
Gossamer Bio Relative Risk vs. Return Landscape
If you would invest 238.00 in Gossamer Bio on October 28, 2025 and sell it today you would earn a total of 32.00 from holding Gossamer Bio or generate 13.45% return on investment over 90 days. Gossamer Bio is currently generating 0.3212% in daily expected returns and assumes 4.8256% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Gossamer, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Gossamer Bio Target Price Odds to finish over Current Price
The tendency of Gossamer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.73 | 90 days | 2.73 | about 62.52 |
Based on a normal probability distribution, the odds of Gossamer Bio to move above the current price in 90 days from now is about 62.52 (This Gossamer Bio probability density function shows the probability of Gossamer Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.4 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Gossamer Bio will likely underperform. Additionally Gossamer Bio has an alpha of 0.291, implying that it can generate a 0.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Gossamer Bio Price Density |
| Price |
Predictive Modules for Gossamer Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Gossamer Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gossamer Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Gossamer Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Gossamer Bio is not an exception. The market had few large corrections towards the Gossamer Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Gossamer Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Gossamer Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.29 | |
β | Beta against Dow Jones | 1.40 | |
σ | Overall volatility | 0.47 | |
Ir | Information ratio | 0.06 |
Gossamer Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Gossamer Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Gossamer Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Gossamer Bio had very high historical volatility over the last 90 days | |
| Gossamer Bio has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 114.7 M. Net Loss for the year was (56.53 M) with profit before overhead, payroll, taxes, and interest of 44.05 M. | |
| Gossamer Bio currently holds about 304.38 M in cash with (3.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Gossamer Bio Trading Down 5.7 percent Heres What Happened |
Gossamer Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Gossamer Stock often depends not only on the future outlook of the current and potential Gossamer Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Gossamer Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 226.2 M | |
| Cash And Short Term Investments | 294.5 M |
Gossamer Bio Fundamentals Growth
Gossamer Stock prices reflect investors' perceptions of the future prospects and financial health of Gossamer Bio, and Gossamer Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Gossamer Stock performance.
| Return On Equity | -7.83 | ||||
| Return On Asset | -0.34 | ||||
| Operating Margin | (3.13) % | ||||
| Current Valuation | 647.58 M | ||||
| Shares Outstanding | 231.46 M | ||||
| Price To Earning | (4.61) X | ||||
| Price To Book | 2.66 X | ||||
| Price To Sales | 14.19 X | ||||
| Revenue | 114.7 M | ||||
| Gross Profit | 44.05 M | ||||
| EBITDA | (39.97 M) | ||||
| Net Income | (56.53 M) | ||||
| Cash And Equivalents | 304.38 M | ||||
| Cash Per Share | 3.29 X | ||||
| Total Debt | 202.88 M | ||||
| Debt To Equity | 3.86 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | (0.36) X | ||||
| Cash Flow From Operations | (3.47 M) | ||||
| Earnings Per Share | (0.69) X | ||||
| Market Capitalization | 624.93 M | ||||
| Total Asset | 315.29 M | ||||
| Retained Earnings | (1.27 B) | ||||
| Working Capital | 264.88 M | ||||
| Current Asset | 441.63 M | ||||
| Current Liabilities | 39.84 M | ||||
About Gossamer Bio Performance
Assessing Gossamer Bio's fundamental ratios provides investors with valuable insights into Gossamer Bio's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Gossamer Bio is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.16) | (0.17) | |
| Return On Capital Employed | (0.25) | (0.24) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (2.20) | (2.31) |
Things to note about Gossamer Bio performance evaluation
Checking the ongoing alerts about Gossamer Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Gossamer Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Gossamer Bio had very high historical volatility over the last 90 days | |
| Gossamer Bio has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 114.7 M. Net Loss for the year was (56.53 M) with profit before overhead, payroll, taxes, and interest of 44.05 M. | |
| Gossamer Bio currently holds about 304.38 M in cash with (3.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Gossamer Bio Trading Down 5.7 percent Heres What Happened |
- Analyzing Gossamer Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Gossamer Bio's stock is overvalued or undervalued compared to its peers.
- Examining Gossamer Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Gossamer Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Gossamer Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Gossamer Bio's stock. These opinions can provide insight into Gossamer Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.